The conversation also explores broader issues surrounding the opioid crisis, including the role of pharmaceutical companies, the limitations of existing treatment models, and the challenges of advancing new approaches within government and healthcare systems. Hubbard outlines the goals of the Texas Ibogaine Initiative, which seeks to secure state funding for clinical trials aimed at evaluating ibogaine through the FDA drug development process.
Videos
The Duncan Trussell Family Hour - #664 Bryan Hubbard
March 1, 2025
In this episode of The Duncan Trussell Family Hour, Bryan Hubbard discusses the growing interest in ibogaine as a potential treatment for opioid addiction and other substance use disorders. Hubbard explains how researchers believe the compound may influence brain chemistry and behavior, while emphasizing that ibogaine requires careful medical screening and supervision due to potential health risks.